Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LIMNLIMN
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LIMINATUS PHARMA INC.

CITADEL ADVISORS LLC holds 56,089 shares of LIMN (LIMINATUS PHARMA INC.), worth $6,192 as of 2026-Q2. The position was decreased (-91.7% shares).

Current Value

$6,192

Current Shares

56,089

Total Value Change

-$37,075

Total Shares Change

-14,841

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
56,089
-91.7%
$6,1920.0%$0.11
0
2026-Q1
Increased
677,518
+855.2%
$116,4650.0%$0.23
24
2025-Q4
New
70,930
-
$43,2670.0%$0.64
31

Other major holders of LIMN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used